3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
162
Carcinoma, Non-Small-Cell Lung
109
Lung Neoplasms
54
Hodgkin Disease
22
Neoplasm Metastasis
16
Recurrence
15
Lymphoma
15
Neoplasms
14
Triple Negative Breast Neoplasms
13
Prostatic Neoplasms
10
Adenocarcinoma of Lung
10
Sarcoma
9
Rhabdomyosarcoma
9
Uterine Cervical Neoplasms
8
Lymphoma, Non-Hodgkin
8
Lymphoma, Large B-Cell, Diffuse
6
Ovarian Neoplasms
5
Mesothelioma, Malignant
5
Breast Neoplasms, Male
5
Small Cell Lung Carcinoma
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
NSCLC
4
Multiple Myeloma
4
Brain Neoplasms
4
Unspecified Adult Solid Tumor, Protocol Specific
3
Mesothelioma
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Follicular
3
Lymphoma, B-Cell, Marginal Zone
3
Interventions
palbociclib
1
exemestane
1
Vinorelbine
1
Therapeutics
1
Tamoxifen
1
Risk Assessment
1
Paclitaxel
1
Letrozole
1
Influenza Vaccines
1
Fulvestrant
1
Focus Groups
1
Epirubicin
1
Drug Therapy
1
Counseling
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Patient Acceptance of Health Care
×
Vinorelbine
×
Clear all
NCT03355157
2024-10-01
PADMA
GBG Forschungs GmbH
Phase 4
Completed
130 enrolled